Conference Overview

As medical science advances, so does our understanding of drug safety and the need for vigilance when it comes to monitoring its usage. In recent years, pharmacovigilance has gained significant attention and importance due to the growing complexity of drug therapies, the emergence of new medicines, and the increased scrutiny of regulatory agencies. This has led to a greater emphasis on monitoring the safety profiles of pharmaceutical products throughout their lifecycle, from pre-marketing clinical trials to post-marketing surveillance.

 

The need for effective pharmacovigilance systems becomes even more crucial as the global population continues to expand, resulting in an increased consumption of medications. Adverse drug reactions (ADRs) can have severe consequences, leading to hospitalizations, prolonged treatments, and in some cases, even fatalities. Therefore, it is imperative to enhance our understanding of ADRs, identify potential risks, and implement appropriate risk mitigation strategies. To efficiently address these challenges, collaboration between international regulatory bodies, healthcare providers, and patients is essential. With a strong focus on patient safety as well as public health and by creating an interconnected network of experts from around the world who are dedicated to advancing our understanding of drug safety and pharmacovigilance, we can create a robust system.

This conference will serve as a knowledge-sharing and networking platform, providing a unique opportunity for researchers, pharmacists, healthcare professionals, industry representatives, and regulatory authorities to come together and discuss the latest trends, challenges, and advancements in pharmacovigilance. By sharing experiences and best practices, we aim to enhance global drug safety and improve patient outcomes. Throughout the conference, we will delve into various topics such as signal detection and management, adverse event reporting and analysis, risk assessment, benefit-risk evaluation, regulatory updates, collaboration and the integration of artificial intelligence and digital technologies in pharmacovigilance.

 

Our esteemed panel of speakers, comprising leading experts from academia, industry, and regulatory agencies, will present their research findings, share case studies, and engage in thought-provoking discussions. The conference will also feature interactive networking opportunities, fostering collaboration and enabling the exchange of ideas.

 

We are delighted to welcome you to the Pharmacovigilance World 2023, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide.
 


Conference Streams Include

 

 

Global PV & Methodologies

Data management & Analytics in PV

PV Automation, AI & Machine Learning

Safety Signals & Management

Pharmacovigilance Regulations

Risk
Management

Patient Centric Drug Safety

Case
Management

Quality &
Compliance

Pharmacovigilance Outsourcing

Medical Devices Safety

Adverse Drug Reactions

 

 

KEY DISCUSSIONS WE'LL BE EXPLORING

  • Pharmacovigilance and globalization
  • Pharmacovigilance in a pandemic world
  • Women and child health care medicines and pharmacovigilance
  • Patient-centric approaches in PV
  • Pharmacovigilance legislation and regulations
  • Harmonization and pharmacovigilance
  • Advanced therapeutic techniques and pharmacovigilance
  • Pharmacovigilance and data management and eudravigilance
  • Post-marketing surveillance in pharmacovigilance
  • PV regulations and challenges
  • Benefit-risk management strategies
  • Risk management and minimization
  • Risk Evaluation and Mitigation
  • Adverse drug reactions reporting
  • Signal detection and post authorization safety
  • Good Pharmacovigilance Practices
  • Innovative approaches to drug safety
  • Strategies to improve PV
  • Real World Evidence in PV
  • Big data and AI in pharmacovigilance
  • Pharmacovigilance Workflows with AI & Automation
  • Other emerging technologies in PV

 

 

WHO SHOULD ATTEND PHARMACOVIGILANCE 2023

 

C-level, Presidents, Senior/Global Vice Presidents, Directors, Directors, Heads & Managers, Scientific Advisors, Consultants and professionals who work for pharmaceutical, biotechnology & devices industries, CROs and service providers involved in Pharmacovigilance and Drug safety.

 

  • Pharmacovigilance
  • Safety & Risk management
  • Drug safety
  • PV Compliance
  • Safety Surveillance
  • Medical Affairs
  • Regulatory Affairs
  • Inspection and Audit
  • Pharmacoepidemiology
  • Post-market studies
  • Medical product safety assessment
  • Drug Research & Development
  • Clinical Pharmacology
  • Medical information
  • Contract outsourcing service providers
  • Health outcomes
  • Sales and Marketing

 

 

 

 

pharmaceutical companies

Speakers

VIEW ALL

There are plenty of opportunities to position yourself as a thought leader & showcase your company.

For enquiries on speaker opportunities please e-mail to speaker@corvusglobalevents.com

Become a Speaker


Wednesday - 1st November 2023

  • 08:50
  • Chairperson’s opening remarks


    Michael Ramcharan

    Michael Ramcharan Managing Director
    Reumat Consulting

Quality & Compliance

  • 09:00
  • Case Study - Supporting real inspections, and establishing and adhering to corrective action plans to enhance pharmacovigilance practices

      Presentation
    Bertrand Sailly

    Bertrand Sailly Associate Director, Pharmacovigilance and Medical Quality
    Takeda

  • 09:30
  • Auditing and Practical Aspects in PV, Hints & Tips

      Presentation
    Antje Baumgarten

    Antje Baumgarten Senior Global System Auditor
    Bayer Healthcare

  • 10:00
  • Quality Management Systems in Pharmacovigilance: Best Practices and Compliance

    • QMS principles and their role in pharmacovigilance.
    • Best practices for implementing QMS in pharmacovigilance processes.
    • How compliance with QMS standards contributes to patient safety and regulatory requirements.

      Presentation
    Lizanne Pistorius

    Lizanne Pistorius Senior Manager Global Patient Safety Operations, QMS & Risk Management
    Aimmune Therapeutics & Nestle Health Science

  • 10:30
  • Business Card Exchange with Morning Coffee/Tea & Discussion

     

         

Safety Signals & Risk Management

  • 10:50
  • Risk management During Drug development

      Presentation
    Mohamed Abdillahi

    Mohamed Abdillahi Director, Risk management Product Lead
    Pfizer

  • 11:20
  • An industrial perspective: Post-marketing Signal Detection and management

      Presentation
    Nadia Hussain

    Nadia Hussain PV Operations Manager (Deputy ASR)
    AbbVie

  • 11:50
  • Challenges and Solutions in Risk Management: A Post-Brexit UK Landscape

      Presentation
    Nick Nikberg

    Nick Nikberg Senior Patient Safety Specialist
    AstraZeneca

  • 12:20
  • Developmental Risk Management - Safety and Risk management Activities During Clinical Trials

      Presentation
    Gauri Utturkar

    Gauri Utturkar Patient Safety Physician
    UCB Pharma

  • 12:50
  • Luncheon & Networking

     

                

  • 13:30
  • Assessing the Quality of ICSRs & the Impact on causality assessment

    • Spontaneous report
    • Quality
    • How is the quality of the notification evaluated?
    • Impact of quality reports on causal assessment

     

      Presentation
    Maria De Los Angeles Hernandez Loli

    Maria De Los Angeles Hernandez Loli Patient Safety Lead Cluster Ecuador - Peru
    Boehringer Ingelheim

  • 14:00
  • Case Study: Development and implementation of additional risk minimisation measure

      Presentation
    Amit Jadhav

    Amit Jadhav Director Global Patient Safety, Internal Medicine and Gene Therapy
    Regeneron

  • 14:30
  • aRMMs implementation challenges

      Presentation
    Zina Sadeq

    Zina Sadeq Director, Regional PV & Alliance Management
    Amicus Therapeutics

Drug Safety Strategies, Colloboration & Regulatory updates

  • 15:00
  • Panel Discussion - Collaborative Approaches to Pharmacovigilance: Integrating Systems for Effective Safety Monitoring and Risk Management

    • The benefits and challenges of integrating pharmacovigilance systems across different organizations, including pharmaceutical companies, regulatory agencies, and healthcare providers.
    • Strategies for developing standardized processes and data sharing agreements to improve collaboration and streamline pharmacovigilance activities
    • The role of technology in facilitating collaborative approaches to pharmacovigilance, such as using AI and machine learning to automate ADR detection and analysis.
    • The importance of stakeholder engagement and communication in building trust and fostering collaboration among different organizations involved in pharmacovigilance
    • Best practices for successful implementation of collaborative pharmacovigilance initiatives


    Michael Ramcharan

    Michael Ramcharan Managing Director
    Reumat Consulting

    Petar Gjorgiev

    Petar Gjorgiev Global Safety Lead
    Regeneron

    Mayssa Aboughannam

    Mayssa Aboughannam Country Safety Team Lead, GCC, Pakistan & Afghanistan
    Johnson & Johnson

    Gauri Utturkar

    Gauri Utturkar Patient Safety Physician
    UCB Pharma

    Mark Perrott

    Mark Perrott Founder and Managing Partner
    Axian Consulting Ltd

  • 15:30
  • Grab your Tea/Coffee

     

         

  • 15:50
  • Key operational learnings from a designed longitudinal RBM Pharmacovigilance study using RWD from a covid-19 vaccination program (population of 7 M spread across 295 counties)

      Presentation
    Aldir Medeiros Filho

    Aldir Medeiros Filho Former Senior Project Manager - Data Sciences Department
    Mitsubishi Tanabe Pharma Europe Ltd

  • 16:20
  • A Round Table on "Medical Errors”


    Michael Ramcharan

    Michael Ramcharan Managing Director
    Reumat Consulting

  • 16:50
  • Ensuring Drug Safety Through International Harmonization of Drug Regulatory Requirements in LATAM

      Presentation
    Cinthya Galicia Quintanar

    Cinthya Galicia Quintanar Senior Manager, Country Safety Lead
    Pfizer

  • 17:20
  • Chairperson’s Closing Remark


    Michael Ramcharan

    Michael Ramcharan Managing Director
    Reumat Consulting

  • 17:30
  • Networking Drinks Session

BRING YOUR TEAM
Delegate Registration

Corvus Global Events recognises the value of learning in teams. There's so much great content!!!

Bring your team and get an extra discount. There are special group packages available. Please email to delegate@corvusglobalevents.comfor more details.

register now

PARTNERS

Partnerships typically involve an exchange of value and frequently include online content, PR, advertising, online & event branding.

For enquiries please e-mail to mediapartner@corvusglobalevents.com

VENUE

 

Holiday Inn London - Kensington
Wrights Lane, Kensington
London W8 5SP
United Kingdom


We make every effort to secure the very best hotel for our attendees with amazing event spaces, so that we’re able to guarantee our attendees the highest quality service and comfort.

 

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now